FDA Investigator George M Ibrahim
George M Ibrahim has inspections in 1 countries as of 30 Sep 2022. George M Ibrahim has collaborated with a combined 735 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
3
Last Inspection Date:
30 Sep 2022
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alberto A Viciedo,
Alia Legaux,
Alice C Silva,
Amber G Wardwell,
Amy Kim,
Amy W Yan Mai,
Angela Jourdain,
Brenda P King,
Constance Desimone,
Courtney N Long,
Daryl A Dewoskin,
Dave M Deroche,
Dipesh K Shah,
Douglas C Kovacs,
Edmund F Mrak, Jr,
Evelyn Taha,
Felix Maldonado,
Helen Verdel,
Jawaid Hamid,
John P Mistler,
Karen E D'orazio,
Keith M Reilly,
Kelli F Dobilas,
Kellie Leveille,
Kristina J Donohue,
Li Li,
Lisa Harlan,
Lisa Mathew,
LTJG Matthew R Palo,
Mark R Mcclain,
Maya M Davis,
Megan A Haggerty,
Melba Trivera Clavell,
Melissa T Roy,
Michael P Sheehan,
Paraluman S Leonin,
Parul M Patel,
Philip F Istafanos, DMV, MS,
Philip Kreiter,
Ramon E Martinez,
Richard H Penta,
Stacey S Degarmo,
Tara G Bizjak,
Valerie J Grecek Trinh
George M Ibrahim's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2003 | FDA 483 | AstraZeneca LP - Form 483, 2003-08-01 |
October, 2004 | EIR | MPL Laboratories - EIR, 2004-10-22 |
October, 2004 | FDA 483 | MPL Laboratories - Form 483, 2004-10-22 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more